General MedicationsInjectionGeneric
VINCRISTINE SULFATE
VINCRISTINE SULFATE
Standard Dose
5MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview VINCRISTINE SULFATE is listed in Drugs@FDA under application 071937 (ANDA).
Marketing status: Discontinued Active ingredient VINCRISTINE SULFATE Form and strength Injectable; Injection - 5MG/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview VINCRISTINE SULFATE is listed in Drugs@FDA under application 071937 (ANDA). Marketing status: Discontinued Active ingredient VINCRISTINE SULFATE Form and strength Injectable; Injection - 5MG/VIAL Sponsor QUAD PHARMS Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.